DK3203999T3 - Substituerede aromatiske forbindelser og farmaceutiske sammensætninger til forebyggelse og behandling af osteoporose - Google Patents

Substituerede aromatiske forbindelser og farmaceutiske sammensætninger til forebyggelse og behandling af osteoporose Download PDF

Info

Publication number
DK3203999T3
DK3203999T3 DK15849675.2T DK15849675T DK3203999T3 DK 3203999 T3 DK3203999 T3 DK 3203999T3 DK 15849675 T DK15849675 T DK 15849675T DK 3203999 T3 DK3203999 T3 DK 3203999T3
Authority
DK
Denmark
Prior art keywords
osteoporosis
prevention
treatment
pharmaceutical compositions
aromatic compounds
Prior art date
Application number
DK15849675.2T
Other languages
Danish (da)
English (en)
Inventor
Lyne Gagnon
Brigitte Grouix
Original Assignee
Liminal Biosciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liminal Biosciences Ltd filed Critical Liminal Biosciences Ltd
Application granted granted Critical
Publication of DK3203999T3 publication Critical patent/DK3203999T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/32—Phenylacetic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/52—Unsaturated compounds containing hydroxy or O-metal groups a hydroxy or O-metal group being bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK15849675.2T 2014-10-10 2015-10-08 Substituerede aromatiske forbindelser og farmaceutiske sammensætninger til forebyggelse og behandling af osteoporose DK3203999T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462062597P 2014-10-10 2014-10-10
PCT/CA2015/000540 WO2016054728A1 (en) 2014-10-10 2015-10-08 Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis

Publications (1)

Publication Number Publication Date
DK3203999T3 true DK3203999T3 (da) 2020-03-30

Family

ID=55652429

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15849675.2T DK3203999T3 (da) 2014-10-10 2015-10-08 Substituerede aromatiske forbindelser og farmaceutiske sammensætninger til forebyggelse og behandling af osteoporose

Country Status (23)

Country Link
US (2) US20180228750A1 (enExample)
EP (1) EP3203999B1 (enExample)
JP (1) JP6700639B2 (enExample)
KR (1) KR20170066476A (enExample)
CN (1) CN106999456B (enExample)
AR (1) AR102246A1 (enExample)
AU (1) AU2015330645B2 (enExample)
BR (1) BR112017007426A2 (enExample)
CA (1) CA2963354A1 (enExample)
DK (1) DK3203999T3 (enExample)
ES (1) ES2785317T3 (enExample)
IL (1) IL251404B (enExample)
MX (1) MX376873B (enExample)
MY (1) MY194308A (enExample)
PH (1) PH12017500638A1 (enExample)
PL (1) PL3203999T3 (enExample)
PT (1) PT3203999T (enExample)
RU (1) RU2709205C2 (enExample)
SG (1) SG11201702868VA (enExample)
TW (1) TWI699200B (enExample)
UY (1) UY36356A (enExample)
WO (1) WO2016054728A1 (enExample)
ZA (1) ZA201702639B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016054725A1 (en) * 2014-10-10 2016-04-14 Prometic Biosciences Inc. Phenylketone carboxylate compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis
AU2015345943B2 (en) * 2014-11-12 2020-03-19 Liminal Biosciences Limited Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration
CN107683135A (zh) 2015-03-09 2018-02-09 因特克林医疗有限公司 用于治疗非酒精性脂肪肝疾病和/或脂肪营养不良的方法
KR20190065252A (ko) * 2016-08-18 2019-06-11 인테크린 테라퓨틱스, 아이엔씨. 골 질환 치료용 PPARγ 작용제
AU2018249822A1 (en) 2017-04-03 2019-10-31 Coherus Biosciences Inc. PPArgamma agonist for treatment of progressive supranuclear palsy
AU2021356346A1 (en) * 2020-10-06 2023-06-15 Pharmaceutique Ingenew Inc. Substituted aromatic compounds and pharmaceutical compositions thereof
MX2024005982A (es) * 2021-11-17 2024-05-30 Natreon Inc Withania somnifera y asparagus racemosus en el tratamiento de enfermedades posmenopausicas.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200720256A (en) * 2005-05-13 2007-06-01 Synta Pharmaceuticals Corp IL-12 modulatory compounds
EP2427416B1 (en) * 2009-05-04 2016-03-09 Prometic Pharma Smt Limited Substituted aromatic compounds and pharmaceutical uses thereof
BRPI1015118A2 (pt) * 2009-05-04 2016-04-12 Prometic Biosciences Inc sais de ácido pentilfenilacético e usos farmacêuticos dos mesmos
PH12013500763B1 (en) * 2010-10-27 2018-07-04 Prometic Pharma Smt Ltd Phenylketone carboxylate compounds and pharmaceutical uses thereof
CN105997967B (zh) * 2010-10-27 2019-08-23 普罗米蒂克医药Smt有限公司 用于治疗癌症的化合物和组合物
TWI742541B (zh) * 2013-03-15 2021-10-11 英商邊緣生物科技有限公司 用於治療肺纖維化、肝纖維化、皮膚纖維化及心臟纖維化之經取代之芳族化合物
TWI689490B (zh) * 2013-03-15 2020-04-01 英商邊緣生物科技有限公司 用於治療纖維化之經取代之芳族化合物及相關方法
WO2016054725A1 (en) * 2014-10-10 2016-04-14 Prometic Biosciences Inc. Phenylketone carboxylate compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis

Also Published As

Publication number Publication date
AR102246A1 (es) 2017-02-15
KR20170066476A (ko) 2017-06-14
BR112017007426A2 (pt) 2018-01-16
CA2963354A1 (en) 2016-04-14
MY194308A (en) 2022-11-27
TW201618762A (zh) 2016-06-01
IL251404B (en) 2020-11-30
WO2016054728A1 (en) 2016-04-14
IL251404A0 (en) 2017-05-29
PT3203999T (pt) 2020-04-23
EP3203999B1 (en) 2020-01-08
RU2017116178A (ru) 2018-11-19
ZA201702639B (en) 2018-06-27
PL3203999T3 (pl) 2020-07-27
UY36356A (es) 2016-06-01
US11185521B2 (en) 2021-11-30
AU2015330645B2 (en) 2020-03-12
PH12017500638A1 (en) 2017-09-25
JP6700639B2 (ja) 2020-05-27
AU2015330645A1 (en) 2017-05-04
CN106999456B (zh) 2020-07-10
SG11201702868VA (en) 2017-05-30
RU2709205C2 (ru) 2019-12-17
MX2017004733A (es) 2017-07-17
ES2785317T3 (es) 2020-10-06
CN106999456A (zh) 2017-08-01
JP2017530180A (ja) 2017-10-12
EP3203999A4 (en) 2018-06-27
EP3203999A1 (en) 2017-08-16
MX376873B (es) 2025-03-07
TWI699200B (zh) 2020-07-21
RU2017116178A3 (enExample) 2019-05-16
US20200237693A1 (en) 2020-07-30
US20180228750A1 (en) 2018-08-16

Similar Documents

Publication Publication Date Title
DK3143025T3 (da) Forbindelser til behandling af spinal muskelatrofi
DK3350157T3 (da) Forbindelser og sammensætninger til intracellulær afgivelse af terapeutiske midler
DK3102673T3 (da) Fremgangsmåder og sammensætninger til behandling af beta-talassæmi
DK3092256T3 (da) Forbindelser og sammensætninger til immunterapi
DK3189074T3 (da) Sammensætninger og metoder til behandling og forebyggelse af inflammation
DK3253382T3 (da) Farmaceutiske sammensætninger til kombinationsterapi
DK3495023T3 (da) Semifluorerede forbindelser og sammensætninger deraf
DK3119797T3 (da) Raav-baserede sammensætninger og fremgangsmåder til behandling af amyotrofisk lateralsklerose
DK3102213T3 (da) Farmaceutiske sammensætninger til behandlingen af inflammatoriske lidelser
DK3277270T3 (da) Sammensætninger og fremgangsmåder til behandling af anæmi
DK3204386T3 (da) Substituerede aminopurinforbindelser, sammensætninger deraf og fremgangsmåder til behandling dermed
DK3524255T3 (da) Sammensætning til behandling af acne
DK3362066T3 (da) Kombinationsterapi til behandling af maligniteter
DK3143026T3 (da) Forbindelser og sammensætninger til induktion af chondrogenese
IL255185A0 (en) 1-heteroaryl-indoline-4-carboxamides as modulators of gpr52 useful for the treatment or prevention of disorders related thereto
DK3328864T3 (da) Terapeutiske forbindelser og sammensætninger til behandling af sociale forstyrrelser og stofmisbrugsforstyrrelser
ZA201702639B (en) Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis
DK3522873T3 (da) Sammensætninger og fremgangsmåder til behandlingen af xerostomi
DK3122367T3 (da) Sammensætninger baseret på safran til forebyggelse og/eller behandling af degenerative øjenlidelser
DK3169405T3 (da) Fremgangsmåder, forbindelser og sammensætninger til behandling af muskel- og skeletsygdomme
DK3403674T3 (da) Farmaceutiske sammensætninger til behandling af smerte
DK3220908T3 (da) Sammensætninger og fremgangsmåder til behandling af endometriose
DK3122743T3 (da) Sammensætninger og fremgangsmåder til behandling af neurodegenerative sygdomme
DK3998067T3 (da) Sammensætninger og fremgangsmåder til behandling af homocystinuri
DK3236961T3 (da) Farmaceutisk sammensætning til forebyggelse eller behandling af cancer